1-20 of 32
David L. McCormick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 706: Efficacy evaluation of BR-9001, a SMEDDS formulation of 3,3’-diindolylmethane, as an inhibitor of preneoplastic and neoplastic lesion development in the prostate of Hi-Myc mice

Genoveva Murillo, Gina Qualter, Xinjian Peng, Miguel Muzzio, Elizabeth R. Glaze, Altaf Mohammed, Maarten C. Bosland, David L. McCormick
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 706.
https://doi.org/10.1158/1538-7445.AM2022-706
Published: 15 June 2022
View articletitled, Abstract 706: Efficacy evaluation of BR-9001, a SMEDDS formulation of 3,3’-diindolylmethane, as an inhibitor of preneoplastic and neoplastic lesion development in the prostate of Hi-Myc mice
Journal Articles

Abstract LB225: Colon cancer preventive efficacy of licofelone and its analogue LFA-9 in PIRC rat model of FAP

Venkateshwar Madka, Nagendra S. Yarla, Gopal Pathuri, Yuting Zhang, Anh Bao, Nicole C. Stratton, Anil Singh, David L. McCormick, Altaf Mohammed, Shizuko Sei, Jennifer Fox, Chinthalapally V. Rao
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB225.
https://doi.org/10.1158/1538-7445.AM2021-LB225
Published: 01 July 2021
View articletitled, Abstract LB225: Colon cancer preventive efficacy of licofelone and its analogue LFA-9 in PIRC rat model of FAP
Journal Articles

Abstract 2730: Exceptional activity of ARN-509 (apalutamide) in prostate cancer prevention in rats

Genoveva Murillo, Xinjian Peng, Miguel Muzzio, Maarten C. Bosland, Elizabeth R. Glaze, Chen Suen, David L. McCormick
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2730.
https://doi.org/10.1158/1538-7445.AM2019-2730
Published: 01 July 2019
View articletitled, Abstract 2730: Exceptional activity of ARN-509 (apalutamide) in prostate cancer prevention in rats
Journal Articles

Abstract 4933: Six-month oral toxicity study of endoxifen in rats

Thomas L. Horn, William D. Johnson, Carol J. Detrisac, Patrick T. Curry, Elizabeth R. Glaze, David L. McCormick
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4933.
https://doi.org/10.1158/1538-7445.AM2018-4933
Published: 01 July 2018
View articletitled, Abstract 4933: Six-month oral toxicity study of endoxifen in rats
Journal Articles

Abstract 4931: Enhanced oral bioavailability of 3,3'-diindolylmethane administered in a self-microemulsifying drug delivery system (SMEDDS)

William D. Johnson, Miguel Muzzio, Thomas L. Horn, Michael A. Zeligs, Elizabeth R. Glaze, David L. McCormick
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4931.
https://doi.org/10.1158/1538-7445.AM2018-4931
Published: 01 July 2018
View articletitled, Abstract 4931: Enhanced oral bioavailability of 3,3'-diindolylmethane administered in a self-microemulsifying drug delivery system (SMEDDS)
Journal Articles

Abstract 3890: Interspecies comparison of in vitro endoxifen metabolism

Miguel Muzzio, Zhihua Huang, Elizabeth R. Glaze, David L. McCormick
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3890.
https://doi.org/10.1158/1538-7445.AM2018-3890
Published: 01 July 2018
View articletitled, Abstract 3890: Interspecies comparison of in vitro endoxifen metabolism
Journal Articles

Abstract 4517: Plasma and tumor pharmacokinetics of IV LMP744, a novel indenoisoquinoline topoisomerase I inhibitor, in a canine phase I study

Julie L. Eiseman, Julianne Holleran, David L. McCormick, Miguel Muzzio, Joseph M. Covey, Chand Khanna, Christina Mazcko, Yves Pommier, Melissa Paolini, Amy Leblanc, Jenna H. Burton, James H. Doroshow, Joseph E. Tomaszewski, Jan H. Beumer
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4517.
https://doi.org/10.1158/1538-7445.AM2015-4517
Published: 01 August 2015
View articletitled, Abstract 4517: Plasma and tumor pharmacokinetics of IV LMP744, a novel indenoisoquinoline topoisomerase I inhibitor, in a canine phase I study
Journal Articles

Abstract 4632: Plasma and tumor pharmacokinetics of IV LMP400, a novel indenoisoquinoline topoisomerase I inhibitor, in a canine phase I study

Julie L. Eiseman, Julianne Holleran, David L. McCormick, Miguel Muzzio, Joseph M. Covey, Chand Khanna, Christina Mazcko, Yves Pommier, Melissa Paoloni, James D. Doroshow, Joseph E. Tomaszewski, Jan H. Beumer
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4632.
https://doi.org/10.1158/1538-7445.AM2014-4632
Published: 01 October 2014
View articletitled, Abstract 4632: Plasma and tumor pharmacokinetics of IV LMP400, a novel indenoisoquinoline topoisomerase I inhibitor, in a canine phase I study
Journal Articles

Abstract 613: Synergistic antiproliferative activity of combined administration of atorvastatin and zoledronic acid in LNCaP and PC3 prostate cancer cells

Xinjian Peng, Liang Yuan, Alimirah Fatouma, Rajendra Mehta, Levy Kopelovich, David L. McCormick
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 613.
https://doi.org/10.1158/1538-7445.AM2012-613
Published: 15 April 2012
View articletitled, Abstract 613: Synergistic antiproliferative activity of combined administration of atorvastatin and zoledronic acid in LNCaP and PC3 prostate cancer cells
Journal Articles

Abstract 3782: Plasma pharmacokinetics of fluorodeoxycytidine, downstream metabolites, and tetrahydrouridine after combined administration to cynomolgus monkeys

Jan H. Beumer, Julianne L. Holleran, David L. McCormick, William D. Johnson, Joseph M. Covey, Myrtle Davis, Julie L. Eiseman
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3782.
https://doi.org/10.1158/1538-7445.AM2012-3782
Published: 15 April 2012
View articletitled, Abstract 3782: Plasma pharmacokinetics of fluorodeoxycytidine, downstream metabolites, and tetrahydrouridine after combined administration to cynomolgus monkeys
Journal Articles

Abstract 1858: Inhibition of oral carcinogenesis in rats by the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)

David L. McCormick, Thomas L. Horn, William D. Johnson, Ronald A. Lubet, Vernon E. Steele
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1858.
https://doi.org/10.1158/1538-7445.AM2011-1858
Published: 15 April 2011
View articletitled, Abstract 1858: Inhibition of oral carcinogenesis in rats by the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
Journal Articles

Abstract 967: Serine proteases as targets for prostate cancer prevention: Identification by analysis of differential gene expression in rodent and human prostate cancers

Shoshana G. Marvin, Karen E.O. Torres, David L. McCormick
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 967.
https://doi.org/10.1158/1538-7445.AM10-967
Published: 15 April 2010
View articletitled, Abstract 967: Serine proteases as targets for prostate cancer prevention: Identification by analysis of differential gene expression in rodent and human prostate cancers
Journal Articles

A pharmacokinetic/pharmacodynamic approach to evaluating the safety of zebularine in non-human primates

William D. Johnson, J. Brooks Harder, Jennifer Naylor, David L. McCormick, Carol J. Detrisac, Elizabeth R. Glaze, Joseph E. Tomaszewski
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 309–310.
Published: 15 April 2006
View articletitled, A pharmacokinetic/pharmacodynamic approach to evaluating the safety of zebularine in non-human primates
Journal Articles

Chronic dietary restriction does not inhibit androgen-dependent prostate carcinogenesis in the Wistar-unilever rat model

David L. McCormick, William D. Johnson, Maarten C. Bosland, Ronald A. Lubet, Vernon E. Steele
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 914–915.
Published: 15 April 2006
View articletitled, Chronic dietary restriction does not inhibit androgen-dependent prostate carcinogenesis in the Wistar-unilever rat model
Journal Articles

Identification of new agents for the prevention of prostate cancer using preclinical animal models

Vernon E. Steele, David L. McCormick, Maarten C. Bosland, K. V. N. Rao, Ronald A. Lubet
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 938.
Published: 01 April 2004
View articletitled, Identification of new agents for the prevention of prostate cancer using preclinical animal models
Journal Articles

Chronic oral toxicity studies of the angiogenesis inhibitor, ammonium tetrathiomolybdate

William D. Johnson, David L. McCormick, Robert L. Morrissey, Elizabeth R. Glaze, Joseph E. Tomaszewski
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 946.
Published: 01 April 2004
View articletitled, Chronic oral toxicity studies of the angiogenesis inhibitor, ammonium tetrathiomolybdate
Journal Articles

Suppression of oral carcinogenesis in rats by the PPARγ agonist, rosiglitazone

David L. McCormick, Thomas L. Horn, William D. Johnson, Jonathan M. Phillips, Ronald A. Lubet, Vernon E. Steele
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 172.
Published: 01 April 2004
View articletitled, Suppression of oral carcinogenesis in rats by the PPARγ agonist, rosiglitazone
Journal Articles

Lack of chemopreventive activity of lycopene in the Wistar-Unilever rat prostate cancer model

Maarten C. Bosland, William D. Johnson, Michael J. Cwik, Ronald A. Lubet, Vernon E. Steele, David L. McCormick
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 900.
Published: 01 April 2004
View articletitled, Lack of chemopreventive activity of lycopene in the Wistar-Unilever rat prostate cancer model
Journal Articles

Chemoprevention of Rat Prostate Carcinogenesis by Early and Delayed Administration of Dehydroepiandrosterone

K. V. N. Rao, William D. Johnson, Maarten C. Bosland, Ronald A. Lubet, Vernon E. Steele, Gary J. Kelloff, David L. McCormick
Journal: Cancer Research
Cancer Res (1999) 59 (13): 3084–3089.
Published: 01 July 1999
View articletitled, Chemoprevention of Rat Prostate Carcinogenesis by Early and Delayed Administration of Dehydroepiandrosterone
Open the PDF for Chemoprevention of Rat Prostate Carcinogenesis by Early and Delayed Administration of Dehydroepiandrosterone in another window
Journal Articles

Chemoprevention of Rat Prostate Carcinogenesis by 9-cis-Retinoic Acid

David L. McCormick, K. V. N. Rao, Vernon E. Steele, Ronald A. Lubet, Gary J. Kelloff, Maarten C. Bosland
Journal: Cancer Research
Cancer Res (1999) 59 (3): 521–524.
Published: 01 February 1999
View articletitled, Chemoprevention of Rat Prostate Carcinogenesis by 9-cis-Retinoic Acid
Open the PDF for Chemoprevention of Rat Prostate Carcinogenesis by 9-cis-Retinoic Acid in another window